The PPARγ Agonist Rosiglitazone Enhances the Radiosensitivity of Human Pancreatic Cancer Cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The PPARγ Agonist Rosiglitazone Enhances the Radiosensitivity of Human Pancreatic Cancer Cells
Authors
Keywords
-
Journal
Drug Design Development and Therapy
Volume Volume 14, Issue -, Pages 3099-3110
Publisher
Informa UK Limited
Online
2020-07-31
DOI
10.2147/dddt.s242557
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma
- (2018) Cheng-Qian Zhong et al. Cancer Medicine
- Rosiglitazone Role in the Expression of KLF6 Caco-2 Colon Cancer Cells
- (2017) Víctor Rojas et al. INTERNATIONAL JOURNAL OF MORPHOLOGY
- Activation of PPARα by clofibrate sensitizes pancreatic cancer cells to radiation through the Wnt/β-catenin pathway
- (2017) J Xue et al. ONCOGENE
- Rosiglitazone enhances radiosensitivity by inhibiting repair of DNA damage in cervical cancer cells
- (2017) Zhengzhe An et al. RADIATION AND ENVIRONMENTAL BIOPHYSICS
- The Androgen Receptor Regulates PPARγ Expression and Activity in Human Prostate Cancer Cells
- (2016) Emuejevoke Olokpa et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Clinical development of new drug–radiotherapy combinations
- (2016) Ricky A. Sharma et al. Nature Reviews Clinical Oncology
- Elevated expression of FABP3 and FABP4 cooperatively correlates with poor prognosis in non-small cell lung cancer (NSCLC)
- (2016) Zhiyuan Tang et al. Oncotarget
- Integrated microRNA-mRNA analyses reveal OPLL specific microRNA regulatory network using high-throughput sequencing
- (2016) Chen Xu et al. Scientific Reports
- Current status and progress of pancreatic cancer in China
- (2015) Quan-Jun Lin WORLD JOURNAL OF GASTROENTEROLOGY
- Peroxisome proliferator-activated receptor γ agonist rosiglitazone inhibits migration and invasion of prostate cancer cells through inhibition of the CXCR4/CXCL12 axis
- (2014) LIANG QIN et al. Molecular Medicine Reports
- Therapeutic options for the management of pancreatic cancer
- (2014) Maria L Rossi WORLD JOURNAL OF GASTROENTEROLOGY
- Recent progress in pancreatic cancer
- (2013) Christopher L. Wolfgang et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Ionizing-radiation induced DNA double-strand breaks: A direct and indirect lighting up
- (2013) Julien Vignard et al. RADIOTHERAPY AND ONCOLOGY
- Cancer and Radiation Therapy: Current Advances and Future Directions
- (2012) Rajamanickam Baskar et al. International Journal of Medical Sciences
- The effects of rosiglitazone on osteoblastic differentiation, osteoclast formation and bone resorption
- (2012) Eui-Sic Cho et al. MOLECULES AND CELLS
- Rosiglitazone and AS601245 Decrease Cell Adhesion and Migration through Modulation of Specific Gene Expression in Human Colon Cancer Cells
- (2012) Angelo Cerbone et al. PLoS One
- Protein Kinase CK2 Triggers Cytosolic Zinc Signaling Pathways by Phosphorylation of Zinc Channel ZIP7
- (2012) K. M. Taylor et al. Science Signaling
- Peroxisome proliferator-activated receptors and cancer: challenges and opportunities
- (2011) Jihan Youssef et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Nuclear Hormone Receptor PPARγas a Therapeutic Target in Major Diseases
- (2011) Martina Victoria Schmidt et al. TheScientificWorldJOURNAL
- Rosiglitazone enhances the radiosensitivity of p53-mutant HT-29 human colorectal cancer cells
- (2010) Shu-Jun Chiu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Combined Low Doses of PPARγ and RXR Ligands Trigger an Intrinsic Apoptotic Pathway in Human Breast Cancer Cells
- (2009) Daniela Bonofiglio et al. AMERICAN JOURNAL OF PATHOLOGY
- Loss of XIAP sensitizes rosiglitazone-induced growth inhibition of colon cancerin vivo
- (2008) Yun Dai et al. INTERNATIONAL JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started